 Sulphadiazine desensitization patients AIDS cerebral toxoplasmosis objectives study efficacy sulphadiazine desensitization protocol patients AIDS cerebral toxoplasmosis CT sulphonamide allergy adequate dose sulphadiazine g/day days effect concurrent corticosteroid CS administration success rate regimen Sixteen patients CT past history current manifestations sulphonamide allergy October December protocol oral administration increments sulphadiazine days Success tolerance oral sulphadiazine day days death present time allergic reactions success overall patients Seven patients final dose g/day dose g/day Concurrent CS administration outcome small number patients sulphadiazine regimen desensitized patients CT allergy optimal first-line treatment aetiology allergy HIV-infected patients mechanisms desensitization works unknown